Acasti Pharma Inc. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Acasti Pharma Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2019 to 2023.
  • Acasti Pharma Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2024 was -$3.6M, a 42.4% increase year-over-year.
  • Acasti Pharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$12.3M, a 22.5% increase from 2022.
  • Acasti Pharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$15.9M, a 7.67% increase from 2021.
  • Acasti Pharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$17.2M, a 20.4% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.3M +$3.58M +22.5% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-21
2022 -$15.9M +$1.32M +7.67% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-21
2021 -$17.2M -$2.92M -20.4% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-23
2020 -$14.3M +$8.63M +37.6% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-21
2019 -$23M Apr 1, 2019 Mar 31, 2020 10-K 2021-06-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.